real-time news and commentary for investors
Friday, Jan 18
Shares of Akorn (AKRX -1.8%) slip after projecting its 2013 EPS to come in below Street...
Shares of Akorn (AKRX -1.8%) slip after projecting its 2013 EPS to come in below Street estimates, despite forecasting record revenue as the niche pharmaceutical company boosts its product pipeline. It now expects to earn $0.57 to $0.61 per share, versus expectations of $0.66. Revenue is anticipated at $325M to $335M, in line with analysts projections of $331M. Read the transcript of the guidance conference here: (Transcript)